Antagonism of mGluR5 in Fragile X: A Randomized, Placebo-Controlled, Proof-of-Concept Study of AFQ056, a Novel, Sub-Type Selective mGluR5 Antagonist
Gomez-Mancilla B., Jacquemont S., Curie A., des Portes V., Torrioli M.G., Berry-Kravis E., Hagerman R.J., Ramos F.J., Cornish K.i.m., He Y. et al., 2011. p. 25 dans 7th International Meeting on Metabotropic Glutamate Receptors, Current Neuropharmacology. Peer-reviewed.
ici le détail